Evaluation and comparison of serological methods for COVID-19 diagnosis

F Gong, H Wei, Q Li, L Liu, B Li - Frontiers in Molecular Biosciences, 2021 - frontiersin.org
The worldwide pandemic of COVID-19 has become a global public health crisis. Various
clinical diagnosis methods have been developed to distinguish COVID-19–infected patients …

The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review

S Paul, LAB Vázquez, PR Reyes-Pérez… - Virus Research, 2022 - Elsevier
Nowadays, one of the major global health concerns is coronavirus disease 2019 (COVID-
19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Nanotechnology‐Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID‐19 Vaccines

C Rinoldi, SS Zargarian, P Nakielski, X Li… - Small …, 2021 - Wiley Online Library
In recent years, the main quest of science has been the pioneering of the groundbreaking
biomedical strategies needed for achieving a personalized medicine. Ribonucleic acids …

A nanoenzyme linked immunochromatographic sensor for rapid and quantitative detection of SARS-CoV-2 nucleocapsid protein in human blood

C Liang, B Liu, J Li, J Lu, E Zhang, Q Deng… - Sensors and Actuators B …, 2021 - Elsevier
The establishment of a simple, low-cost, high-sensitive and rapid immunoassay for detecting
SARS-CoV-2 antigen in human blood is an effective mean of discovering early SARS-CoV-2 …

Mechanisms of coronavirus infectious disease 2019-related neurologic diseases

RS Klein - Current opinion in neurology, 2022 - journals.lww.com
Mechanisms of coronavirus infectious disease 2019-related ne... : Current Opinion in
Neurology Mechanisms of coronavirus infectious disease 2019-related neurologic diseases …

SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies

A Salimi-Jeda, S Abbassi, A Mousavizadeh… - International …, 2021 - Elsevier
More than a year after the SARS-CoV-2 pandemic, the Coronavirus disease 19 (COVID-19)
is still a major global challenge for scientists to understand the different dimensions of …

Mucormycosis and COVID-19-associated mucormycosis: insights of a deadly but neglected mycosis

LC García-Carnero, HM Mora-Montes - Journal of Fungi, 2022 - mdpi.com
The ongoing COVID-19 pandemic has quickly become a health threat worldwide, with high
mortality and morbidity among patients with comorbidities. This viral infection promotes the …

[HTML][HTML] Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies

H Latifi-Pupovci - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the outbreak of
unusual viral pneumonia that emerged in late 2019 in the city of Wuhan, China. Since then …

Risk of Severe Illness and Risk Factors of Outcomes of COVID‐19 in Hospitalized Patients with Chronic Liver Disease in a Major US Hospital Network

A Krishnan, L Prichett, Y Liu, P Ting… - Canadian Journal of …, 2022 - Wiley Online Library
Background and Aim. Underlying comorbidities are an emerging risk factor for more severe
coronavirus disease 2019 (COVID‐19). However, its impact on patients with chronic liver …

[HTML][HTML] Status epilepticus as a complication after COVID-19 mRNA-1273 vaccine: a case report

R Šín, D Štruncová - World Journal of Clinical Cases, 2021 - ncbi.nlm.nih.gov
BACKGROUND We present a rare case of status epilepticus in a 56-year-old man which
arose as a complication after vaccination with the coronavirus disease 2019 (COVID-19) …